Dechert Advised Alcentra Capital on Shareholder Activism Matters, Strategic Alternatives Process, Subsequent Merger With Crescent Capital BDC
February 12, 2020
February 12, 2020
PHILADELPHIA, Pennsylvania, Feb. 12 -- Dechert, a law firm, issued the following news:
Dechert advised Alcentra Capital Corporation on shareholder activism matters and in connection with its strategic alternatives process and subsequent merger with Crescent Capital BDC, Inc. The combined company has a portfolio in excess of $900 million and trades on the NASDAQ under the ticker symbol "CCAP".
Under the terms of the merger agreement, in exchange for approximate . . .
Dechert advised Alcentra Capital Corporation on shareholder activism matters and in connection with its strategic alternatives process and subsequent merger with Crescent Capital BDC, Inc. The combined company has a portfolio in excess of $900 million and trades on the NASDAQ under the ticker symbol "CCAP".
Under the terms of the merger agreement, in exchange for approximate . . .